Cargando…

Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis

The diagnostic management of systemic granulomatosis is a difficult clinical exercise. The most frequent etiologies are tuberculosis and sarcoidosis. However, it is important to search as well for the other causes of granulomas, especially infections and malignancies, the prognosis of which can be p...

Descripción completa

Detalles Bibliográficos
Autores principales: Serraj, Khalid, Alaoui, Habiba, El Oumri, Ahmed Amine, Barrimi, Mohamed, Bachir, Houda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681776/
https://www.ncbi.nlm.nih.gov/pubmed/33240697
http://dx.doi.org/10.7759/cureus.11101
_version_ 1783612607684411392
author Serraj, Khalid
Alaoui, Habiba
El Oumri, Ahmed Amine
Barrimi, Mohamed
Bachir, Houda
author_facet Serraj, Khalid
Alaoui, Habiba
El Oumri, Ahmed Amine
Barrimi, Mohamed
Bachir, Houda
author_sort Serraj, Khalid
collection PubMed
description The diagnostic management of systemic granulomatosis is a difficult clinical exercise. The most frequent etiologies are tuberculosis and sarcoidosis. However, it is important to search as well for the other causes of granulomas, especially infections and malignancies, the prognosis of which can be poor without adequate treatment. A 67-year-old immunocompetent patient presented with granulomatous adenitis without caseous necrosis. The etiological evaluation had revealed neurological, pulmonary and lymph node systemic cryptococcosis. Conventional antifungal therapy with the triple combination Amphotericin B - Flucytosine - Fluconazole has not been effective, indicating administration of voriconazole. The evolution was rapidly favorable with apyrexia after 48 hours, disappearance of clinical symptoms, normalization of biological parameters of cerebrospinal fluid (CSF) and major improvement of radiological abnormalities. This clinical case is original by the disseminated involvement, the patient's non-immunocompromised status and the primary resistance to amphotericin B. Our findings underline the importance of carrying out an exhaustive evaluation, reflecting on cryptococcosis in any systemic granulomatosis and knowing the various therapeutic alternatives, in particular, voriconazole if primary response to amphotericin B has not been obtained.
format Online
Article
Text
id pubmed-7681776
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76817762020-11-24 Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis Serraj, Khalid Alaoui, Habiba El Oumri, Ahmed Amine Barrimi, Mohamed Bachir, Houda Cureus Internal Medicine The diagnostic management of systemic granulomatosis is a difficult clinical exercise. The most frequent etiologies are tuberculosis and sarcoidosis. However, it is important to search as well for the other causes of granulomas, especially infections and malignancies, the prognosis of which can be poor without adequate treatment. A 67-year-old immunocompetent patient presented with granulomatous adenitis without caseous necrosis. The etiological evaluation had revealed neurological, pulmonary and lymph node systemic cryptococcosis. Conventional antifungal therapy with the triple combination Amphotericin B - Flucytosine - Fluconazole has not been effective, indicating administration of voriconazole. The evolution was rapidly favorable with apyrexia after 48 hours, disappearance of clinical symptoms, normalization of biological parameters of cerebrospinal fluid (CSF) and major improvement of radiological abnormalities. This clinical case is original by the disseminated involvement, the patient's non-immunocompromised status and the primary resistance to amphotericin B. Our findings underline the importance of carrying out an exhaustive evaluation, reflecting on cryptococcosis in any systemic granulomatosis and knowing the various therapeutic alternatives, in particular, voriconazole if primary response to amphotericin B has not been obtained. Cureus 2020-10-23 /pmc/articles/PMC7681776/ /pubmed/33240697 http://dx.doi.org/10.7759/cureus.11101 Text en Copyright © 2020, Serraj et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Serraj, Khalid
Alaoui, Habiba
El Oumri, Ahmed Amine
Barrimi, Mohamed
Bachir, Houda
Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
title Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
title_full Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
title_fullStr Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
title_full_unstemmed Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
title_short Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
title_sort effective voriconazole in an immunocompetent patient with amphotericin b resistant systemic cryptococcal granulomatosis
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681776/
https://www.ncbi.nlm.nih.gov/pubmed/33240697
http://dx.doi.org/10.7759/cureus.11101
work_keys_str_mv AT serrajkhalid effectivevoriconazoleinanimmunocompetentpatientwithamphotericinbresistantsystemiccryptococcalgranulomatosis
AT alaouihabiba effectivevoriconazoleinanimmunocompetentpatientwithamphotericinbresistantsystemiccryptococcalgranulomatosis
AT eloumriahmedamine effectivevoriconazoleinanimmunocompetentpatientwithamphotericinbresistantsystemiccryptococcalgranulomatosis
AT barrimimohamed effectivevoriconazoleinanimmunocompetentpatientwithamphotericinbresistantsystemiccryptococcalgranulomatosis
AT bachirhouda effectivevoriconazoleinanimmunocompetentpatientwithamphotericinbresistantsystemiccryptococcalgranulomatosis